ibrutinib price is a medication used to treat certain types of cancer, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). The price of ibrutinib can be quite high, often exceeding $10,000 per month in the U.S. However, costs can vary based on factors such as insurance coverage, discounts, and location. Patients should check with their healthcare provider and insurance company to understand their specific costs and potential assistance programs.
